Longitudinal effects of Johnson & Johnson COVID-19 vaccination on metabolic biomarkers in type 2 diabetes mellitus in Ethiopia

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

117

Figures (1-5)

Tables (1-8)

Sum=190

Publishing Process of This Article

Item

Count

Browse

Download

Sum=41

Jun 15, 2025 (publication date) through Jun 16, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Diabetes. Jun 15, 2025; 16(6): 105447
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105447

Table 3 Interrelationships among lipid parameters and eicosanoids

^aP < 0.05.

Citation: Edae CK, Bedada AT, Teklemariam MD, Girma T, Gebre SG. Longitudinal effects of Johnson & Johnson COVID-19 vaccination on metabolic biomarkers in type 2 diabetes mellitus in Ethiopia. World J Diabetes 2025; 16(6): 105447
URL: https://www.wjgnet.com/1948-9358/full/v16/i6/105447.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i6.105447